Duo Wan
State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Erratum: Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation.
Journal: Molecular therapy. Oncology
Published: June 03, 2025
Peripheral TERT- positive leukocytes as a biomarker of the local and systemic immune failure in early-stage lung adenocarcinoma progression.
Journal: Molecular biomedicine
Published: March 26, 2025
Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation.
Journal: Molecular therapy. Oncology
Published: November 25, 2024
Postoperative continuous saline bladder irrigation reduces active urinary cancer cells: a prospective study in NMIBC.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 24, 2024
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma.
Journal: Journal of hematology & oncology
Published: September 15, 2024
Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer.
Journal: Discover oncology
Published: August 24, 2024
SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment.
Journal: BMC medicine
Published: March 09, 2022
Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis.
Journal: Translational andrology and urology
Published: December 22, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026